Why Do Large B-Cell Lymphoma Patients With High Tumor Mutation Burden Relapse on CAR T-Cell Therapy?
Researchers explored this question at ASH and shared data suggesting genomic instability in tumors with high TMB likely enables them to hide from immune attack.
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Scripps Research scientists have discovered how some tumors endure DNA damage, revealing a potential new way to target them. The DNA inside our cells is constantly exposed to damage, and one of the ...
This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...
From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
Twenty-five years ago, the release of the first complete Arabidopsis thaliana genome marked a pivotal turning point in plant ...
Researchers say in future it may be possible to grow personalized organoids from patient’s own tissue, to test potential treatments in advance.
The 2025 college football regular season is in full force. You can easily check out the Oklahoma Sooners’ schedule as SportsGrid looks into each game right here. Stay ahead of the game and elevate ...
Using termite and cockroach genomes, researchers built phylogenetic trees from transposons, paving a new way to differentiate ...
Gen Z is on a dopamine diet. A trend has swept TikTok, where young people are being bored on purpose: putting their phones down, staring into space, doing nothing. It’s symbiotic of an age where ...
With all the momentum the Denver Broncos (9-2) have built this season, it is hard to imagine them wanting to take a week off. Denver beat the Kansas City Chiefs 22-19 on Nov. 16, further increasing ...
Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results